Note: CSU has research teams pursuing four vaccine development projects, using an engineered bacterium, a combination of light and vitamin B2, a modified poxvirus used against smallpox, and a tuberculosis vaccine platform.
High-resolution photos of Mary Jackson and her team: https://col.st/p9rv7
Mary Jackson, a professor in the Department of Microbiology, Immunology and Pathology at Colorado State University, has been studying tuberculosis for the last 25 years. Originally from France, she received a doctoral degree from the Pasteur Institute, where the vaccine to prevent tuberculosis was discovered in the early 1900s. The Bacillus Calmette-Guerin or BCG vaccine is the most widely used of all vaccines and reaches more than 80% of newborns and infants around the world, according to the World Health Organization.
Jackson recently spoke with SOURCE about a new research project she’s leading at Colorado State University to see if the BCG vaccine platform could be an effective way to fight COVID-19.